Large Molecule Bioanalytical Services

Smithers Avanza supports the development of large-molecule therapeutics from discovery through phase IV, with expertise in bioassaysand ultra-sensitivity ligand-bindingassays. The services focus on development, validation and sample analysis for PK/TK, ADA, bioassays and fit-for purpose biomarker studies. Smithers Avanza supports biologics/monoclonal & polyclonal antibodies/bi-specific antibodies/CAR-T/TCR/biosimilars and biobetters

Smithers Avanza is expanding its North American operations with the addition of a laboratory in New Jersey. The new site will add 18,500 sq. ft of laboratory space and will be GLP-, GCP-, GMP-compliant and CLIA certified. The company will add translational science capabilities in drug discovery bioassays, biomarker discovery, mechanism of action (MoA) studies, ultra-sensitive biomarker studies by HRMS, and others to support biotherapeutic development. View the press release.

News & Events
Smithers Avanza Promotes Dr. Ira DuBey to President

Dr. DuBey will be responsible for the strategy of the bioanalytical services business as it expands in number of locations, team members,...

News & Events
Smithers Avanza Bioanalytical Services Adds Capabilities With Second Facility on East Coast

Bioanalytical Services will add 18,500 sq. ft  laboratory in New Jersey to support client demand for services and will be ...

News & Events
Smithers Avanza Bioanalytical Services Names Two New Directors

Nadia Kulagina, PhD, appointed as Director of Science and Brian Hoffpauir, PhD, appointed as Director of Operations.

News & Events
Smithers Avanza Bioanalytical Services Names New Business Development Director

Bioanalytical Services names Robert L. Moore, Ph.D. to the position of Director, Business Development

Read More Connect
Read More Events - PharmSci360
Read More Events - Immunogencity
Read More Careers at Smithers